Investor Relations OTCQB: SVFC
Webcasts: Corporate Presentation Webcast, January 9, 2012 at 11:30 a.m. (PT)
Intellicell® Biosciences Ticker Symbol for Stocks: OTCQB: SVFC
For Investor Relations Questions & Answers: Phone: 212-249-3050
www.sec.gov – Link to Intellicell Bioscience’s SEC Listing
Corporate Summary
- Experienced management team in regenerative medicine
- Top tier scientific and medical advisory group
- Ultrasound based patent pending manufacturing process
- Addresses multiple medical treatment areas with significant unmet clinical needs such as osteoarthritis, gingival gum regeneration, sports medicine, and multiple sclerosis
- First autologous VFC process for enhanced cellular yields without culturing cells or using enzymatic digestion
Proven Management and Seasoned Board Of Directors
- All Filings
- Annual
- Quarterly
- Current Reports
- Proxies
- Ownership
| Filing Date | Form Type | Description | View |
|---|---|---|---|
| Feb 14, 2013 | 3 | Initial statement of beneficial ownership of securities | htmlpdf |
| Jan 14, 2013 | 3 | Initial statement of beneficial ownership of securities | htmlpdf |
| Sep 14, 2012 | 3 | Initial statement of beneficial ownership of securities | htmlpdf |
| Sep 14, 2012 | 4 | Statement of changes in beneficial ownership of securities | htmlpdf |
| Jun 14, 2012 | 3 | Initial statement of beneficial ownership of securities | htmlpdf |